The Global Sutures Market, by Product Type (Absorbable Sutures (Natural Sutures and Synthetic Sutures (Monocryl Sutures, AbsVicryl Sutures, Polyglycoloc Sutures, Polydioxanone Sutures and Others) and Non-Absorbable Sutures (Nylon Sutures, Stainless Steel Sutures, Prolene Sutures and Others) , by Application (Cardiovascular Surgeries, Ophthalmic Surgeries, General Surgeries, Gynecology Surgeries, Orthopedic Surgeries and Other Surgeries), by Material (Monofilament and Multifilament), by Raw Origin (Monofilament and Multifilament) by End User (Hospitals, Ambulatory Care Centres, Nursing Homes, Clinics and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 3,688.50 million in 2022 and expected to exhibit a CAGR of 8.3% over the forecast period (2022-2030), as highlighted in a new report published by Coherent Market Insights.

Increasing technological advancements create huge opportunities for growth in the global sutures market. For instance, in September 2019, Golnit Ltd., a Ukraine-based medical device company, launched its new polytetrafluoroethylene surgical suture which is non-absorbable in nature. This suture is indicated for wound healing in dental and general surgery procedures. Moreover, in April 2021, Dolphin Sutures, an India-based manufacturer of surgical sutures, announced the launch of non-absorbable polytetrafluoroethylene sutures for the first time in India to expand its Dental product portfolio. Polytetrafluoroethylene is a fluoropolymer of tetrafluoroethylene and is very strong, biologically inert, and knots well.

Global Sutures Market – COVID-19 Impact (Impact on Manufacturing)

Lockdown or shutdown was imposed in many countries due to the COVID-19 which had a negative impact on the economy of the private healthcare sector globally. The lockdown resulted in the closure of industrial establishments, except the manufacturing of essential commodities. There was a disruption in the supply chain of products. Consequently, the COVID-19 pandemic has affected the economy by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets Supply chains and manufacturing activities in India, China, the U.S., and others have been disrupted due to the lockdown, whereas countries such as Thailand, Indonesia, Singapore, and others are facing problems with the transportation of raw materials. The COVID-19 pandemic had a negative economic impact on the global sutures market, owing to the decreased number of surgeries during the COVID-19 pandemic. For instance, according to an article published by the National Center for Biotechnology Information, a set of databases providing access to biomedical and genomic information, in December 2020, the weekly rate of surgical procedures did not decrease significantly during week 1 of the COVID period (March 11, 2020–March 31, 2020) when compared to the equivalent period in 2019. However, it decreased by 78 percent by week 2 and by 83 percent by week 3 as compared to the equivalent period in 2019. This study was carried out in Ontario, Canada by utilizing health administrative data sets of all hospital-based scheduled and urgent surgical procedures. Thus, due to the decreased number of surgeries, the COVID-19 pandemic had a negative economic impact on the global sutures market.

Browse 48 Market Data Tables and 50 Figures spread through 245 Pages and in-depth TOC on “Sutures Market”- Global Forecast to 2030, by Product Type (Absorbable Sutures (Natural Sutures and Synthetic Sutures (Monocryl Sutures, AbsVicryl Sutures, Polyglycoloc Sutures, Polydioxanone Sutures and Others) and Non-Absorbable Sutures (Nylon Sutures, Stainless Steel Sutures, Prolene Sutures and Others), by Application (Cardiovascular Surgeries, Ophthalmic Surgeries, General Surgeries, Gynecology Surgeries, Orthopedic Surgeries and Other Surgeries), by  Material (Monofilament and Multifilament), by Raw Origin (Monofilament and Multifilament) by End User (Hospitals, Ambulatory Care Centres, Nursing Homes, Clinics and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

To know the latest trends and insights prevalent in the Global Sutures Market, click the link below:

https://www.coherentmarketinsights.com/market-insight/sutures-market-5039

Key companies in the market are focusing on product launch which is expected to drive the market growth over the forecast period.

For instance, in April 2021, Dolphin Sutures, a global leader in surgical sutures, announced the expansion of its product portfolio for the first time in India, to launch non-absorbable Polytetrafluoroethylene (PTFE) sutures. PTFE suture is a monofilament non-absorbable, extremely soft and smooth material composed of a strand of polytetrafluoroethylene (PTFE).

Key Takeaways of the Global Sutures Market:

  • The global sutures market is expected to exhibit a CAGR of 8.3% over the forecast period, owing to increasing number of cardiovascular surgeries. For instance, according to an article published in Elsevier B.V., Netherlands based publishing company, in 2018, estimated that 10,000 cardiothoracic surgeons in 6,000 centers globally perform more than 2 million open heart operations per year.
  • Among product type, the absorbable sutures segment is expected to account for the largest market share in 2022, owing to recommendation by government to use absorbable sutures is expected to drive the growth of the segment over the forecast period. For instance, in June 2021, Ethicon, Inc., a subsidiary of Johnson & Johnson Medical Devices Companies announced that the National Institute for Health and Care Excellence (NICE) had issued new medical technologies guidance (MTG), recommending the use of plus sutures in surgeries within the National Health Service (NHS). Ethicon plus sutures are the only sutures with triclosan available worldwide with antibacterial protection offered by IRGACARE MP antibacterial sutures (triclosan) and have been shown in vitro to inhibit bacterial colonization of the suture for seven days or more. 2-5 plus sutures reduce the risk of surgical site infections (SSIs) by nearly 30%.
  • Key players operating in the global sutures market include Medtronic Plc, Johnson & Johnson, SMI, Advanced Medical Solutions Group plc, GMD Group (General Medical Disposable), Bentley Healthcare Pvt. Ltd., Lotus Surgicals, Teleflex Incorporated, Sutumed, Lux Sutures, CliniSut, Smith & Nephew Plc, B. Braun Melsungen AG, CONMED Corporation, Unilene, Riverpoint Medical, Unisur Lifecare Pvt. Ltd., Orion Sutures India Pvt Ltd, Dolphin Sutures, Peters Surgical, Meril Life Sciences Pvt. Ltd., Corza Medical, Healthium Medtech Limited, Surgical Sutures Private Limited, DemeTECH Corporation, and Vitrex Medical A/S

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo